Immunogenic peptides from Pap31 and SCS-α of Bartonella bacilliformis: One step closer to a rapid diagnostic tool for Carrion’s disease
- Cláudia Gomes(corresponding author),
- ,
- Juana Del Valle-Mendoza,
- Mayumi Matsuoka,
- Hospital Clínic – Universitat de Barcelona,
- ,
- Universidad Peruana de Ciencias Aplicadas,
- Universidad Científica del Sur,
- Instituto de Investigación Nutricional,
- National Institute of Infectious Diseases
Open access
Publication Information
Output type
Original language
EnglishArticle number
917Journal (Volume, Issue Number)
Pathogens (Volume 10, Issue 8)Publication milestones
- Published - 08/2021
Publication status
Publication IDs
- Scopus: 85111660194
Abstract
Bartonella bacilliformis is the causal agent of Carrion’s disease, an overlooked illness endemic in the Andean Mountains with Peru being the most affected country. The diagnostic of this illness is a challenge due to the limited resources and the common symptomatology with other infectious diseases. The goal of this study was to identify immunogenic peptides from Pap31 and succinyl-CoA synthetase α (SCS-α) of B. bacilliformis that might be suitable for developing a serologic tool. The immunodominant character of Pap31 and SCS-α was determined byWestern blotting and in-silico analysis. Subsequently, 35 peptides were selected for epitope mapping and their immunoreactivity was tested by enzyme-linked immunosorbent assay (ELISA). A total of 30 sera were tested including pre-exposed people with high IgM levels for Pap31/SCS-α (23 sera), patients (2 sera) as well as 5 sera with no reactivity to Pap31/SCS-α. The results indicate that Pap31-8 (187QAIGSAILKGTKDTGT202) and SCS-α-12 (59IFASVAEGKEKTGANA74) are the most immunogenic peptides, with Pap31-8 showing potential to discriminate between B. bacilliformis and the remaining Bartonella spp., and SCS-α-12 differentiating Bartonella spp. from other microorganisms.
Funding Details
Access to documents
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
